Goettingen, Germany, July 29, 2012 --(PR.com
)-- Cyagen produces the world's most comprehensive list of research-use stem cells. Offerings include embryonic stem cells and somatic stem cells from various species, along with their genetically modified derivatives.
In addition, Cyagen produces specialized cell culture media, differentiation media, cryopreservation media and an assortment of related reagents optimized for use with our cells. Also offered are contract research services for stem cell derivation, in vitro and in vivo characterization, gene expression, gene silencing, genetic modification and much more.
Joerg Ronnenberg, chief executive officer of MoBiTec GmbH, said: "This is an important step for the strategy to make a technology transfer of Cyagen's expertise and their products to a quality distributor in order to increase the representation on the market. This agreement with a well-known leader in stem cell technology will have a major impact on the sales of stem cell products in Germany and other European countries."
Cyagen is a life sciences company committed to bringing high-quality reagents and services to the life sciences community at favorable prices.
MoBiTec GmbH offers superior research tools for molecular and cell biology. In parallel to its own product line, MoBiTec distributes products from several international companies in Germany and across the world.